Go to the list of all blogs
Allana's Avatar
published in Blogs
Sep 25, 2026
SRTY vs TZA: Comparing Two -3x Inverse Russell 2000 ETFs

SRTY vs TZA: Comparing Two -3x Inverse Russell 2000 ETFs

Key Takeaways

  • Both SRTY and TZA aim for daily results equal to three times the inverse (-3x) of the Russell 2000 Index, positioning them as structurally similar leveraged inverse ETFs suited mainly for short-term tactical applications.
  • SRTY features a net expense ratio of 0.95%, a modest edge over TZA’s 0.99%, which could matter for longer tactical holds.
  • Each fund relies on synthetic exposure via swaps, futures, and cash equivalents instead of direct stock ownership, leading to limited traditional diversification and notable sensitivity to daily compounding.
  • The underlying Russell 2000 Index focuses on U.S. small-cap companies, with key sector weights in health care (around 20%), financials (around 18%), and industrials (around 15%).
  • Liquidity levels are adequate for both products, supporting use by institutional and retail investors looking for short-term inverse small-cap exposure.
  • These ETFs provide amplified downside participation distinct from long-only small-cap vehicles, yet they require active monitoring and are not designed for multi-day holds without oversight due to volatility decay.

Why These ETFs Stand Out

ProShares UltraPro Short Russell2000 (SRTY) and Direxion Daily Small Cap Bear 3X ETF (TZA) offer closely matched choices for investors seeking leveraged inverse exposure to U.S. small-cap equities. Instead of competing with traditional long-only small-cap funds, these products support hedging strategies or bearish outlooks on the Russell 2000 Index. Their similar structures make them worth comparing when small-cap volatility or sector shifts affect positioning and risk decisions.

An Overview of SRTY

SRTY targets daily results, before fees and expenses, that correspond to three times the inverse (-3x) of the Russell 2000 Index’s daily performance. It uses a synthetic approach built on swaps, futures contracts, and cash equivalents, resulting in a portfolio of roughly 10–15 holdings centered on these instruments. Sector exposures track the benchmark, with emphasis on health care, financials, and industrials. The net expense ratio is 0.95%. As a passive vehicle with daily rebalancing, SRTY resets its exposure each trading day, setting it apart from unleveraged or long-only small-cap options. I also checked this using Tickeron’s AI Screener to see how the ETF compares to others in the category.

An Overview of TZA

TZA follows the same primary goal: daily investment results, before fees and expenses, equal to three times the inverse (-3x) of the Russell 2000 Index. It similarly depends on swaps, futures, and cash instruments, producing a compact portfolio of about 12 holdings. Sector allocations track the small-cap benchmark closely, led by health care, financials, and industrials. The net expense ratio stands at 0.99%. Daily rebalancing keeps the leveraged inverse target intact, framing the fund as a tactical instrument in the inverse equity space.

The Russell 2000 Context

The Russell 2000 Index includes roughly 2,000 U.S. small-capitalization companies across varied sectors, with meaningful allocations to health care, financials, and industrials. Factors such as interest rate expectations, economic growth paths, and credit conditions often shape small-cap cycles. Regulatory changes in lending, healthcare, or energy can act as triggers, while earnings variability and liquidity issues represent ongoing risks in this segment. Flows into or out of small-cap equities tend to reflect broader risk appetite and rotation trends over market cycles.

Performance and Positioning Insights

Across recent market cycles, both SRTY and TZA have shown the amplified volatility expected from their -3x daily objectives, with returns drifting from the index over multi-day periods because of compounding effects. Relative positioning reveals small cost differences, where SRTY’s lower expense ratio may offer a slight efficiency benefit during sustained inverse exposure. Volatility levels stay comparable given matching leverage and benchmark focus, although liquidity nuances can affect execution during busy trading sessions. Sector trends within the Russell 2000, particularly in healthcare and financials, continue to shape performance for both products over longer horizons.

How I Use Tickeron’s AI Screener

In my research process, I often turn to Tickeron’s AI Screener to filter ETFs and stocks by technical patterns, fundamentals, trends, and volatility signals. It allows quick scans across thousands of securities with customizable criteria like industry, market cap, and performance metrics, helping surface relevant ideas more efficiently than manual review. This tool has proven useful when evaluating inverse products like these for short-term positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SRTY, TZA

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SRTY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SRTY turned positive on October 13, 2026. Looking at past instances where SRTY's MACD turned positive, the stock continued to rise in 41 of 42 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +7.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTY advanced for three days, in 246 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 161 of 177 cases where SRTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for SRTY moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 25 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

SRTY broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks daily investment results that correspond to three times the inverse (-3x) of the daily performance of the Russell 2000® Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a measure of small-cap U.S. stock market performance. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
View a ticker or compare two or three
SRTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Inverse Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.